myFibroScan vs TapGI

FibroScan® is the non-invasive gold standard solution for comprehensive management of liver health. FibroScan® is powered by three unique, patented and validated biomarkers, LSM by VCTE™ (Liver Stiffness Measurement) and CAP™ (Controlled Attenuation Parameter) that benefit from a worldwide clinical evidence with over 5300+ peer-reviewed publications and 180+ international guidelines. myFibroScan app is your everyday FibroScan® companion to access Interpretation Guide and FibroScan® based scores in an easy, fast and intuitive way : The Interpretation Guide utilizes data from clinical studies to assist providers in interpreting FibroScan® examination results. Scores enhance FibroScan® liver disease assessment with biological markers. Scores are presented as educational services intended for licensed healthcare professionals. While the scores are about specific medical and healthcare issues, they are not a substitute for/or replacement of personalized medical advice and are not intended to be used as the sole basis for making individualized medical or health-related decisions. • Fast is an aid to identify at risk MASH patients defined as MASH + NAS≥4 + F≥2. Good to excellent performance in cohorts from different clinical settings (MASLD tertiary care unit, screening, bariatric surgery) and geographical origins (USA, Europe, Asia). Several publications advocate the use of Fast. • Agile 3+ is an aid to identify MASLD patients with advanced fibrosis by combining LSM by VCTE™ and routine clinical parameters to reduce the need for liver biopsy. High clinical performances are demonstrated in large external validation cohorts from different geographical origins. • Agile 4 is an aid to early identify MASLD patients with cirrhosis by combining LSM by VCTE™ and routine clinical parameters. It can help the physicians to manage the disease to prevent liver-related complications such as hepatocellular carcinoma. High clinical performances are demonstrated in large external validation cohorts from different geographical origin. MASH Treatment Eligibility Tool to eliminate the Guesswork. This patient management tool embeds treatment recommendations based on the patient’s FibroScan® results and the latest AASLD Guidance.

Turn your exam date into a focused daily study plan. TapGI brings gastroenterology board review into one calm, organized workspace for fellows and medical professionals. Build knowledge with spaced flashcards, practice board-style questions, work through clinical cases, and connect what you learn with images and the GI Atlas. A PLAN FOR EACH DAY Set your exam date and study target. TapGI schedules new material and reviews, helps you focus on weak areas, and shows the workload ahead. PRACTICE IN DIFFERENT WAYS - Recall key concepts with spaced flashcards. - Test your reasoning with MCQs and answer explanations. - Work through clinical decisions in multi-step cases. - Review endoscopy, pathology, and imaging with image cards. SEE YOUR PROGRESS Follow coverage, readiness, and topic mastery across the GI curriculum. Readiness measures your progress within TapGI. Review your study history and return to material that needs more attention. EXPLORE THE GI ATLAS Search topic guides, clinical images, grading systems, key numbers, and board traps. Open references alongside your study material to put individual facts in context. BUILT FOR FOCUSED STUDY A consistent Midnight design keeps the material easy to scan. Adjust text size, customize swipe actions, set optional reminders, and study with supported keyboard or Bluetooth remote controls. Core content is bundled for offline reading and study. Optional iCloud backup helps you preserve your progress. ACCESS AND TAPGI PRO The Atlas, dashboard, progress views, settings, and a 30-item high-yield sample are available without a subscription. The sample includes recall cards, MCQs, image cards, and clinical cases, using the same card interactions as the full deck. Full scheduled study sessions require TapGI Pro. Both plans provide the same study access: - Monthly: 3-day free trial, then $19.99 per month. - Yearly: 3-day free trial, then $199.99 per year, billed annually. Trials are available to eligible new subscribers. Payment is charged to your Apple Account after the trial, or at purchase if you are not eligible. Subscriptions renew automatically unless canceled at least 24 hours before the current period ends. Manage or cancel in your App Store account settings. Prices are in U.S. dollars. TapGI is available in the United States. YOUR PRIVACY No account is required. TapGI has no advertising SDK and does not sell personal data. A low-detail, pseudonymous usage summary is shared by default to help improve the app. You can turn sharing off and queue deletion in Settings > Backup & Privacy. Optional backups use your private iCloud storage. TapGI is for education and exam preparation. It is not medical advice and must not be used for patient care or clinical decision-making. Privacy Policy: https://tapmedical.org/privacy-policy.html Terms of Use (EULA): https://www.apple.com/legal/internet-services/itunes/dev/stdeula/